<DOC>
	<DOC>NCT01044524</DOC>
	<brief_summary>This study will investigate the absorption, distribution, metabolism and excretion after giving 2000 mg 14C-SLV334 via a 1-hour infusion. The absolute bioavailability will also be determined.</brief_summary>
	<brief_title>Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria healthy nonsmoking subjects Exclusion Criteria QTc &gt; 430 ms; positive drug screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>14C labeled ADME (Aborption Distribution Metabolism and Elimination) study</keyword>
	<keyword>Phase I</keyword>
</DOC>